Advanced search
Publication Cover
Critical Reviews in Biotechnology Volume 35, 2015 - Issue 2
Submit an article Journal homepage
18,809
Views
175
CrossRef citations to date
0
Altmetric
Review Article

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

Timo RathDivision of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA,
,
Kristi BakerDivision of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA,
,
Jennifer A. DumontBiogen Idec, Weston, MA, USA,
,
Robert T. PetersBiogen Idec, Cambridge, MA, USA,
,
Haiyan JiangBiogen Idec, Cambridge, MA, USA,
,
Shuo-Wang QiaoDepartment of Immunology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, and
,
Wayne I. LencerDivision of Gastroenterology, Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
,
Glenn F. PierceBiogen Idec, Weston, MA, USA,
&
Richard S. BlumbergDivision of Gastroenterology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, Correspondence[email protected]
 show all
Pages 235-254 | Received 14 Mar 2013, Accepted 26 Jun 2013, Published online: 24 Oct 2013

Citations (175)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (20)

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L. Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutiérrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J. Blanco, Cruz Santos, José L. Rodríguez-Peralto, Laura Sanz & Luis Álvarez-Vallina. (2023) A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. OncoImmunology 12:1.
Read now
Thomas Müller, Carolin Tasser, Michael Tesar, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch & Kristina Ellwanger. (2023) Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method. mAbs 15:1.
Read now
Andrea Matucci, Francesca Nencini, Emanuele Vivarelli, Susanna Bormioli, Enrico Maggi & Alessandra Vultaggio. (2021) Immunogenicity-unwanted immune responses to biological drugs – can we predict them?. Expert Review of Clinical Pharmacology 14:1, pages 47-53.
Read now
Federica Lo Bello, Philip M. Hansbro, Chantal Donovan, Irene Coppolino, Sharon Mumby, Ian M. Adcock & Gaetano Caramori. (2020) New drugs under development for COPD. Expert Opinion on Emerging Drugs 25:4, pages 419-431.
Read now
Susanna Navarro & Salvador Ventura. (2019) Computational re-design of protein structures to improve solubility. Expert Opinion on Drug Discovery 14:10, pages 1077-1088.
Read now
Dilip K. Challa, Xiaoli Wang, Héctor Pérez Montoyo, Ramraj Velmurugan, Raimund J. Ober & E. Sally Ward. (2019) Neonatal Fc receptor expression in macrophages is indispensable for IgG homeostasis. mAbs 11:5, pages 848-860.
Read now
Johnny Mahlangu. (2018) rFVIIIFC for hemophilia A prophylaxis. Expert Review of Hematology 11:12, pages 937-943.
Read now
Patrick J. Kennedy, Carla Oliveira, Pedro L. Granja & Bruno Sarmento. (2018) Monoclonal antibodies: technologies for early discovery and engineering. Critical Reviews in Biotechnology 38:3, pages 394-408.
Read now
Elisabeth Lobner, Anne-Sophie Humm, Georg Mlynek, Konstantin Kubinger, Michael Kitzmüller, Michael W. Traxlmayr, Kristina Djinović-Carugo & Christian Obinger. (2017) Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex. mAbs 9:7, pages 1088-1104.
Read now
Miro J. Eigenmann, Ludivine Fronton, Hans Peter Grimm, Michael B. Otteneder & Ben-Fillippo Krippendorff. (2017) Quantification of IgG monoclonal antibody clearance in tissues. mAbs 9:6, pages 1007-1015.
Read now
Chris Spahr, Kannan Gunasekaran, Kenneth W. Walker & Stone D.-H. Shi. (2017) High-resolution mass spectrometry confirms the presence of a hydroxyproline (Hyp) post-translational modification in the GGGGP linker of an Fc-fusion protein. mAbs 9:5, pages 812-819.
Read now
Saman Soleimanpour, Tahereh Hassannia, Mahdieh Motiee, Abbas Ali Amini & S. A. R. Rezaee. (2017) Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties. Critical Reviews in Biotechnology 37:3, pages 371-392.
Read now
Sung In Lim & Inchan Kwon. (2016) Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids. Critical Reviews in Biotechnology 36:5, pages 803-815.
Read now
Yao-Yun Fan, Lindsay B. Avery, Mengmeng Wang, Denise M. O'Hara, Sheldon Leung & Hendrik Neubert. (2016) Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice. mAbs 8:5, pages 848-853.
Read now
Roland E. Kontermann. (2016) Half-life extended biotherapeutics. Expert Opinion on Biological Therapy 16:7, pages 903-915.
Read now
Marcus E Carr & Bartholomew J Tortella. (2015) Emerging and future therapies for hemophilia. Journal of Blood Medicine 6, pages 245-255.
Read now
Haixia Wu, Kristopher Truncali, Julie Ritchie, Rachel Kroe-Barrett, Sanjaya Singh, Anne S Robinson & Christopher J Roberts. (2015) Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1. mAbs 7:6, pages 1072-1083.
Read now
Yasmina Noubia Abdiche, Yik Andy Yeung, Javier Chaparro-Riggers, Ishita Barman, Pavel Strop, Sherman Michael Chin, Amber Pham, Gary Bolton, Dan McDonough, Kevin Lindquist, Jaume Pons & Arvind Rajpal. (2015) The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity. mAbs 7:2, pages 331-343.
Read now
Tianlei Ying, Yang Feng, Yanping Wang, Weizao Chen & Dimiter S. Dimitrov. (2014) Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases. mAbs 6:5, pages 1201-1210.
Read now
Kristi Baker, Timo Rath, Michal Pyzik & Richard S Blumberg. (2014) Neonatal Fc receptors for IgG drive CD8+ T cell-mediated anti-cancer immunosurveillance at tolerogenic mucosal sites. OncoImmunology 3:2.
Read now

Articles from other publishers (155)

Lisa LaManna, Chih-Hsuan Chou, Hanqin Lei, Elisabeth R. Barton & Pal Maliga. (2023) Chloroplast transformation for bioencapsulation and oral delivery using the immunoglobulin G fragment crystallizable (Fc) domain. Scientific Reports 13:1.
Crossref
Da Won Lee, Yong Seong Lee, Jeong Hwan Lee, Hyun Joo Chung, Chae Eun Lee, Jong Seok Lim, Kisung Ko, Jin Wook Kim, Joongwon Choi & Soon Chul Myung. (2023) Insect cell‐derived human CD200‐Fc increases zonula occludens‐1 tight junction protein in urothelial carcinoma cells. Entomological Research 53:10, pages 380-389.
Crossref
Gang Wu, Chuanfei Yu, Qinghe Tong, Wenbo Wang, Xi Huang, Hao Li & Lan Wang. (2023) Interlaboratory Co-validation of a UPLC-ToF MS MAM Method for Truncations of a Fc Fusion Protein. Current Pharmaceutical Biotechnology 24:10, pages 1315-1325.
Crossref
Soyeon Oh, Kibum Kim, Yang Joo Kang, Hyunjoo Hwang, Yerin Kim, Peter Hinterdorfer, Mi Kyung Kim, Kinarm Ko, Young Koung Lee, Do-Sun Kim, Soon Chul Myung & Kisung Ko. (2023) Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice. Plant Cell Reports 42:7, pages 1203-1215.
Crossref
Yang Yang, Qiqi Xia, Lujia Zhou, Yan Zhang, Zhixin Guan, Junjie Zhang, Zongjie Li, Ke Liu, Beibei Li, Donghua Shao, Yafeng Qiu, Zhiyong Ma & Jianchao Wei. (2023) B602L-Fc fusion protein enhances the immunogenicity of the B602L protein of the African swine fever virus. Frontiers in Immunology 14.
Crossref
Kotone Matsuyama, Chieko Kurihara, Francis P. Crawley & Sandor Kerpel-Fronius. (2023) Utilization of genetic information for medicines development and equitable benefit sharing. Frontiers in Genetics 14.
Crossref
Gregory M. Jacobson, Kirsty Kraakman, Olivia Wallace, Jolyn Pan, Alex Hennebry, Grant Smolenski, Ray Cursons, Steve Hodgkinson, Adele Williamson & William Kelton. (2023) Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep. Biotechnology Reports 38, pages e00791.
Crossref
Yvette N. Lamb & Sheridan M. Hoy. (2023) Eftrenonacog Alfa: A Review in Haemophilia B. Drugs 83:9, pages 807-818.
Crossref
Fahimeh Zakeri, Hamid Latifi-Navid, Zahra-Soheila Soheili, Mehdi Sadeghi, Seyed Shahriar Arab, Shahram Samiei, Ehsan Ranaei Pirmardan, Sepideh Taghizadeh, Hamid Ahmadieh & Ali Hafezi-Moghadam. (2022) Design, construction and in vivo functional assessment of a hinge truncated sFLT01. Gene Therapy 30:3-4, pages 347-361.
Crossref
Theint Aung, William S. Grubbe, Rebecca J. Nusbaum & Juan L. Mendoza. (2023) Recent and future perspectives on engineering interferons and other cytokines as therapeutics. Trends in Biochemical Sciences 48:3, pages 259-273.
Crossref
Robert A. Saxton, Caleb R. Glassman & K. Christopher Garcia. (2022) Emerging principles of cytokine pharmacology and therapeutics. Nature Reviews Drug Discovery 22:1, pages 21-37.
Crossref
Hyung Jin Jeon, Bo Kyoung Choi, Seo In Hwang, Soo Hyun Kim, Gil Jung Kim, Jae Chan Park, Zung Yoon Yang & Kwang Yeon Hwang. (2022) Optimization for Simultaneous Removal of Product/Process-Related Impurities of Peptide Fc-Fusion Protein Using Cation Exchange Chromatography. Processes 10:11, pages 2359.
Crossref
Jacqueline Kar Kei Mark, Crystale Siew Ying Lim, Fazlina Nordin & Gee Jun Tye. (2022) Expression of mammalian proteins for diagnostics and therapeutics: a review. Molecular Biology Reports 49:11, pages 10593-10608.
Crossref
Yajie Liu, Xilin Bai, Chengliang Lyu, Jing Fang, Fan Zhang, Wen-Hao Wu, Wei Wei & Wen-Bin Zhang. (2022) Mechano-bioconjugation Strategy Empowering Fusion Protein Therapeutics with Aggregation Resistance, Prolonged Circulation, and Enhanced Antitumor Efficacy. Journal of the American Chemical Society 144:40, pages 18387-18396.
Crossref
Carlynne Choy, Lee Yong Lim, Lai Wah Chan, Zhixiang Cui, Shirui Mao & Tin Wui Wong. (2022) Exploring Intestinal Surface Receptors in Oral Nanoinsulin Delivery. Pharmacological Reviews 74:4, pages 962-983.
Crossref
Eugene M. Obeng, Isaac Fianu & Michael K. Danquah. (2022) Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development. Nano Today 46, pages 101580.
Crossref
Yan-Xin Niu, Zhao-Xu Xu, Li-Feng Yu, Yong-Ping Lu, Yan Wang, Ce Wu, Yi-Bo Hou, Jia-Ning Li, Shengqiang Huang, Xinyue Song, Xinyu Wang, Jiaqi Wang, Binyu Li, Yingrui Guo, Zhaojin Yu, Lin Zhao, Dong-Xu Yi & Min-Jie Wei. (2022) Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy. International Immunopharmacology 109, pages 108783.
Crossref
Isabel UWAGBOE, Ian M. ADCOCK, Federica LO BELLO, Gaetano CARAMORI & Sharon MUMBY. (2022) New drugs under development for COPD. Minerva Medica 113:3.
Crossref
Yuanxin Li, Jing Sun, Jingjing Li, Kai Liu & Hongjie Zhang. (2022) Engineered protein nanodrug as an emerging therapeutic tool. Nano Research 15:6, pages 5161-5172.
Crossref
Yuchen Wang, Chenxuan Zhao, Yang Liu, Chao Wang, Haojie Jiang, Yiqiao Hu & Jinhui Wu. (2022) Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis. Molecular Pharmaceutics 19:5, pages 1273-1293.
Crossref
Xinfang Xie, Jingyi Li, Pan Liu, Manliu Wang, Li Gao, Feng Wan, Jicheng Lv, Hong Zhang & Jing Jin. (2022) Chimeric Fusion between Clostridium Ramosum IgA Protease and IgG Fc Provides Long-Lasting Clearance of IgA Deposits in Mouse Models of IgA Nephropathy. Journal of the American Society of Nephrology 33:5, pages 918-935.
Crossref
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, Matthieu Gracia, Aubin Pitiot, Caroline Denevault-Sabourin, Nicolas Joubert, Jean-Pierre Pouget, Valérie Gouilleux-Gruart, Nathalie Heuzé-Vourc’h, Débora Lanznaster, Sophie Poty & Thomas Sécher. (2022) Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics 233, pages 108022.
Crossref
Patrick G. Holder, Shion A. Lim, Christine S. Huang, Preeti Sharma, Yavuz S. Dagdas, Beyza Bulutoglu & Jonathan T. Sockolosky. (2022) Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114112.
Crossref
Ashley A. Stegelmeier, Lisa A. Santry, Matthew M. Guilleman, Kathy Matuszewska, Jessica A. Minott, Jacob G. E. Yates, Brenna A. Y. Stevens, Sylvia P. Thomas, Sierra Vanderkamp, Kiersten Hanada, Yanlong Pei, Amira D. Rghei, Jacob P. van Vloten, Madison Pereira, Brad Thompson, Pierre P. Major, James J. Petrik, Byram W. Bridle & Sarah K. Wootton. (2022) AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma. Biomedicines 10:2, pages 362.
Crossref
Pierpaolo Falcetta, Michele Aragona, Alessandra Bertolotto, Cristina Bianchi, Fabrizio Campi, Monia Garofolo & Stefano Del Prato. (2022) Insulin discovery: A pivotal point in medical history. Metabolism 127, pages 154941.
Crossref
Kathy Matuszewska, Simone ten Kortenaar, Madison Pereira, Lisa A. Santry, Duncan Petrik, Kin-Ming Lo, Byram W. Bridle, Sarah K. Wootton, Jack Lawler & Jim Petrik. (2022) Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer. Gynecologic Oncology 164:1, pages 154-169.
Crossref
Julio Rosenstock & Stefano Del Prato. (2022) Basal weekly insulins: the way of the future!. Metabolism 126, pages 154924.
Crossref
Karin M. Torres-Obreque, Giovanna P. Meneguetti, Jorge J. Muso-Cachumba, Valker A. Feitosa, João H.P.M. Santos, Sónia P.M. Ventura & Carlota O. Rangel-Yagui. (2022) Building better biobetters: From fundamentals to industrial application. Drug Discovery Today 27:1, pages 65-81.
Crossref
Vivek Chavda, Soham Sheta, Divyesh Changani & Disha Chavda. 2021. Computation in Bioinformatics. Computation in Bioinformatics 101 120 .
Hans Van der Weken, Raquel Sanz Garcia, Niek N. Sanders, Eric Cox & Bert Devriendt. (2021) Antibody-Mediated Targeting of Antigens to Intestinal Aminopeptidase N Elicits Gut IgA Responses in Pigs. Frontiers in Immunology 12.
Crossref
Mark A. Jarosinski, Balamurugan Dhayalan, Yen-Shan Chen, Deepak Chatterjee, Nicolás Varas & Michael A. Weiss. (2021) Structural principles of insulin formulation and analog design: A century of innovation. Molecular Metabolism 52, pages 101325.
Crossref
Ravindra Kumar, Asya V. Grinberg, Huiming Li, Tzu-Hsing Kuo, Dianne Sako, Lavanya Krishnan, Katia Liharska, Jia Li, Rosa Grenha, Michelle C. Maguire, Steven D. Briscoe, R. Scott Pearsall, Brantley R. Herrin, Rajasekhar N. V. S. Suragani & Roselyne Castonguay. (2021) Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily. Scientific Reports 11:1.
Crossref
Lu Shan, Nydia Van Dyk, Nantaporn Haskins, Kimberly M. Cook, Kim L. Rosenthal, Ronit Mazor, Sonia Dragulin-Otto, Yu Jiang, Herren Wu, William F. Dall’Acqua, Martin J. Borrok, Melissa M. Damschroder & Vaheh Oganesyan. (2021) In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance. Communications Biology 4:1.
Crossref
Hyung Il Kim, Jinhyeon Kim, Hyori Kim, Hyeri Lee, Yong Sik Yoon, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang, Sun Young Kim & Seung-Jae Myung. (2021) Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Cκ fragment antibody. Scientific Reports 11:1.
Crossref
Calef Sánchez-Trasviña, Miguel Flores-Gatica, Daniela Enriquez-Ochoa, Marco Rito-Palomares & Karla Mayolo-Deloisa. (2021) Purification of Modified Therapeutic Proteins Available on the Market: An Analysis of Chromatography-Based Strategies. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Yujie Shi, An Lu, Xiangyu Wang, Zakia Belhadj, Jiancheng Wang & Qiang Zhang. (2021) A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharmaceutica Sinica B 11:8, pages 2396-2415.
Crossref
Cláudia Azevedo, Soraia Pinto, Sopisa Benjakul, Jeannette Nilsen, Hélder A. Santos, Giovanni Traverso, Jan Terje Andersen & Bruno Sarmento. (2021) Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery. Advanced Drug Delivery Reviews 175, pages 113778.
Crossref
Biaggio Uricoli, Lacey A. Birnbaum, Priscilla Do, James M. Kelvin, Juhi Jain, Emma Costanza, Andrew Chyong, Christopher C. Porter, Sarwish Rafiq & Erik C. Dreaden. (2021) Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy. Advanced Healthcare Materials 10:15.
Crossref
Article Editorial. (2021) Resolution of the Expert council on current issues of prescribing clotting factor VIII with prolonged half-life (INN — Efmoroctocog alfa) in patients with hemophilia A. Russian Journal of Pediatric Hematology and Oncology 8:2, pages 142-143.
Crossref
Pia Gattinger, Shiva Izadi, Clemens Grünwald-Gruber, Somanath Kallolimath & Alexandra Castilho. (2021) The Instability of Dimeric Fc-Fusions Expressed in Plants Can Be Solved by Monomeric Fc Technology. Frontiers in Plant Science 12.
Crossref
Chang Liu, Yeon Su Kim, John Hok-Nin Lowe & Shan Chung. (2021) A cell-based FcRn-dependent recycling assay for predictive pharmacokinetic assessment of therapeutic antibodies. Bioanalysis 13:14, pages 1135-1144.
Crossref
H.A. Daniel Lagassé, Louis B. Hopkins, Wojciech Jankowski, Marc G. Jacquemin, Zuben E. Sauna & Basil Golding. (2021) Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16. Frontiers in Immunology 12.
Crossref
Alexandros Makis, Ersi Voskaridou, Ioannis Papassotiriou & Eleftheria Hatzimichael. (2021) Novel Therapeutic Advances in β-Thalassemia. Biology 10:6, pages 546.
Crossref
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, Kaewta Rattanapisit, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Eakachai Prompetchara, Chutitorn Ketloy, Supranee Buranapraditkun, Wassana Wijagkanalan, Kittipan Tharakhet, Papatsara Kaewpang, Kantinan Leetanasaksakul, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Kiat Ruxrungtham, Arunee Thitithanyanont & Waranyoo Phoolcharoen. (2021) Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates. Frontiers in Plant Science 12.
Crossref
Takayuki Ozawa, Masato Morikawa, Yasuyuki Morishita, Kazuki Ogikubo, Fumiko Itoh, Daizo Koinuma, Per-Åke Nygren & Kohei Miyazono. (2021) Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice. iScience 24:5, pages 102488.
Crossref
Panagiotis F. Christopoulos, Torleif T. Gjølberg, Stig Krüger, Guttorm Haraldsen, Jan Terje Andersen & Eirik Sundlisæter. (2021) Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Frontiers in Immunology 12.
Crossref
Hye-Jin Han, Jin-Hyuk Lim, Hyun-Myoung Cha, Ji-Hun Lee & Dong-Il Kim. (2021) Utilization of Glucocorticoids as Additives for Enhanced Sialylation of Fc-fusion Protein in CHO Cell Cultures. Biotechnology and Bioprocess Engineering 26:2, pages 286-293.
Crossref
Sanghwan Ko, Migyeong Jo & Sang Taek Jung. (2021) Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. BioDrugs 35:2, pages 147-157.
Crossref
Matteo Nicola Dario Di Minno, Alessandro Di Minno, Ilenia Calcaterra, Ernesto Cimino, Francesco Dell'Aquila & Massimo Franchini. (2020) Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies. Seminars in Thrombosis and Hemostasis 47:01, pages 032-042.
Crossref
Matthew J. McNulty, David Z. Silberstein, Brooks T. Kuhn, Hal S. Padgett, Somen Nandi, Karen A. McDonald & Carroll E. Cross. (2021) Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives. Free Radical Biology and Medicine 163, pages 10-30.
Crossref
Timo Rath, Markus F. Neurath & Raja Atreya. (2021) Molecular Imaging and its Applications in Selected GI Diseases. Techniques and Innovations in Gastrointestinal Endoscopy 23:1, pages 87-98.
Crossref
Juliette Lamamy, Pierre Boulard, Guillaume Brachet, Sébastien Tourlet, Valérie Gouilleux-Gruart & Yanis Ramdani. (2021) “Ways in which the neonatal Fc-receptor is involved in autoimmunity”. Journal of Translational Autoimmunity 4, pages 100122.
Crossref
Mamoon Rashid, Monzurul A. Roni & Mehbuba Rahman. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery 277 294 .
Timo Rath, Markus F. Neurath & Raja Atreya. 2021. Molecular Imaging. Molecular Imaging 153 165 .
Fang Zheng & Chang-Guo Zhan. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 191 201 .
Brian A. Baldo & Nghia H. PhamBrian A. Baldo & Nghia H. Pham. 2021. Drug Allergy. Drug Allergy 533 593 .
Bastiaan L. Duivelshof, Amarande Murisier, Julien Camperi, Szabolcs Fekete, Alain Beck, Davy Guillarme & Valentina D'Atri. (2020) Therapeutic Fc‐fusion proteins: Current analytical strategies. Journal of Separation Science 44:1, pages 35-62.
Crossref
Shannon L. Meeks & Sébastien Lacroix‐Desmazes. (2020) Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy. Haemophilia 26:6, pages 958-965.
Crossref
Wanling Liang, Harry W. Pan, Driton Vllasaliu & Jenny K. W. Lam. (2020) Pulmonary Delivery of Biological Drugs. Pharmaceutics 12:11, pages 1025.
Crossref
Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini & Sahar Awwad. (2020) Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 12:10, pages 999.
Crossref
Article Editorial. (2020) Resolution of the Expert сouncil on сurrent issues in the treatment of patients with hemophilia A with clotting factor VIII with prolonged half-life (INN – Efmoroctocog alfa). Russian Journal of Pediatric Hematology and Oncology 7:3, pages 102-103.
Crossref
Marina Tuyishime & Guido Ferrari. (2020) Engineering antibody-based molecules for HIV treatment and cure. Current Opinion in HIV and AIDS 15:5, pages 290-299.
Crossref
Banghui Zhu, Guosheng Wu, Chen Wang, Yongqiang Xiao, Jian Jin, Kangan Wang, Yong Jiang, Yu Sun, Daofeng Ben & Zhaofan Xia. (2020) Soluble cluster of differentiation 74 regulates lung inflammation through the nuclear factor-κB signaling pathway. Immunobiology 225:5, pages 152007.
Crossref
Mengzhe Wang, Hui Wang, Crystal Q. Niu, Tao Zhang, Zhanhong Wu & Zibo Li. (2020) Tetrazine-TCO Ligation: A Potential Simple Approach to Improve Tumor Uptake through Enhanced Blood Circulation. Bioconjugate Chemistry 31:7, pages 1795-1803.
Crossref
Leon F. Garcia-Martinez, Carol J. Raport, Ethan W. Ojala, Benjamin Dutzar, Katie Anderson, Erica Stewart, Brian Kovacevich, Brian Baker, Jens Billgren, Michelle Scalley-Kim, Charlie Karasek, Dan Allison & John A. Latham. (2020) Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 93-103.
Crossref
Angelina Mimoun, Sandrine Delignat, Ivan Peyron, Victoria Daventure, Maxime Lecerf, Jordan D. Dimitrov, Srinivas V. Kaveri, Jagadeesh Bayry & Sébastien Lacroix-Desmazes. (2020) Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance. Frontiers in Immunology 11.
Crossref
Reeju Amatya, Taehoon Park, Seungmi Hwang, JaeWook Yang, Yoonjin Lee, Heesun Cheong, Cheol Moon, Hyun Duck Kwak, Kyoung Ah Min & Meong Cheol Shin. (2020) Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides. Toxins 12:5, pages 313.
Crossref
Margaux Lejeune, Murat Cem Köse, Elodie Duray, Hermann Einsele, Yves Beguin & Jo Caers. (2020) Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology 11.
Crossref
Gizette Sperinde, Diana Montgomery & Daniel T. Mytych. (2020) Clinical Immunogenicity Risk Assessment for a Fusion Protein. The AAPS Journal 22:3.
Crossref
Ekta Seth Chhabra, Tongyao LiuJohn KulmanSusannah Patarroyo-WhiteBuyue YangQi Lu, Douglas DragerNancy MooreJiayun LiuAmy M. HolthausJurg M. SommerAyman IsmailDeana RabinovichZhan LiuArjan van der FlierAllison GoodmanChris FurchtMark TieTyler CarlageRandy MauldinTerrence M. DobrowskyZhiqian LiuOblaise Mercury, Lily ZhuBaisong Mei, Volker Schellenberger, Haiyan JiangGlenn F. PierceJoe SalasRobert Peters. (2020) BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice. Blood 135:17, pages 1484-1496.
Crossref
Benjamin M. Scott & William P. Sheffield. (2019) Engineering the serpin α 1 ‐antitrypsin: A diversity of goals and techniques . Protein Science 29:4, pages 856-871.
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Stanley C. Jordan, Noriko Ammerman & Ashley Vo. (2020) Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics. Transplantation 104:1, pages 17-23.
Crossref
Namik Akkilic, Mathias Liljeblad, Stefan Blaho, Mikko Hölttä, Fredrik Höök & Stefan Geschwindner. (2019) Avidity-Based Affinity Enhancement Using Nanoliposome-Amplified SPR Sensing Enables Low Picomolar Detection of Biologically Active Neuregulin 1. ACS Sensors 4:12, pages 3166-3174.
Crossref
Kyungbo Kim, Pereira Araujo, Nikhil Hebbar, Ziyuan Zhou, Xirong Zheng, Fang Zheng, Vivek M Rangnekar & Chang-Guo Zhan. (2019) Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer. Protein Engineering, Design and Selection 32:3, pages 159-166.
Crossref
Wenwen Bi, Wei Xu, Liang Cheng, Jing Xue, Qian Wang, Fei Yu, Shuai Xia, Qi Wang, Guangming Li, Chuan Qin, Lu Lu, Lishan Su & Shibo Jiang. (2019) IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies. PLOS Pathogens 15:12, pages e1008082.
Crossref
A. R. Satvik Iyengar, Shreya Gupta, Snehal Jawalekar & Abhay H. Pande. (2019) Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 703-714.
Crossref
R. S. Pearsall, M. V. Davies, M. Cannell, J. Li, J. Widrick, A. W. Mulivor, S. Wallner, M. E. Troy, M. Spaits, K. Liharska, D. Sako, R. Castonguay, S. Keates, A. V. Grinberg, R. N. V. S. Suragani & R. Kumar. (2019) Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. Scientific Reports 9:1.
Crossref
H. A. Daniel Lagassé, Hartmut Hengel, Basil Golding & Zuben E. Sauna. (2019) Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity. The AAPS Journal 21:4.
Crossref
R.R.C. New, B.D. Moore, W. Butcher, R. Mahood, M.S. Lever, S. Smither, L. O'Brien, S.A. Weller, M. Bayliss, L.C.D. Gibson, C. Macleod, M. Bogus, R. Harvey, N. Almond & E.D. Williamson. (2019) Antibody-mediated protection against MERS-CoV in the murine model. Vaccine 37:30, pages 4094-4102.
Crossref
Alexandra Schifferli, Falk Nimmerjahn & Thomas Kühne. (2019) Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?. Frontiers in Immunology 10.
Crossref
Gang Niu, Guohao Wang, Joseph Lau, Lixin Lang, Orit Jacobson, Ying Ma, Dale O. Kiesewetter, Shaoliang Zhang & Xiaoyuan Chen. (2018) Antidiabetic Effect of Abextide, a Long‐Acting Exendin‐4 Analogue in Cynomolgus Monkeys. Advanced Healthcare Materials 8:12, pages 1800686.
Crossref
Rahela Zaman, Rowshan Ara Islam, Nabilah Ibnat, Iekhsan Othman, Anuar Zaini, Chooi Yeng Lee & Ezharul Hoque Chowdhury. (2019) Current strategies in extending half-lives of therapeutic proteins. Journal of Controlled Release 301, pages 176-189.
Crossref
Nina Hanke, Claudia Kunz, Meinolf Thiemann, Harald Fricke & Thorsten Lehr. (2019) Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients. Pharmaceutics 11:4, pages 152.
Crossref
Roselyne Castonguay, Jennifer Lachey, Samantha Wallner, Jamie Strand, Katia Liharska, Abigail E. Watanabe, Marishka Cannell, Monique V. Davies, Dianne Sako, Megan E. Troy, Lavanya Krishnan, Aaron W. Mulivor, Huiming Li, Sarah Keates, Mark J. Alexander, R. Scott Pearsall & Ravi Kumar. (2019) Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle. Journal of Pharmacology and Experimental Therapeutics 368:3, pages 435-445.
Crossref
Safieh Aghaabdollahian, Reza Ahangari Cohan, Dariush Norouzian, Fatemeh Davami, Mohammad Reza Asadi Karam, Fatemeh Torkashvand, Golnaz Vaseghi, Reza Moazzami & Sakineh Latif Dizaji. (2019) Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology. Scientific Reports 9:1.
Crossref
Atefeh Ghorbani Aghdam, Saeed Moradhaseli, Farnoush Jafari, Paria Motahari, Sepideh Samavat, Rasoul Mahboudi & Shayan Maleknia. (2019) Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design. PLOS ONE 14:1, pages e0210712.
Crossref
Valentina Lorenzoni, Isotta Triulzi & Giuseppe Turchetti. (2018) Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective. BMC Health Services Research 18:1.
Crossref
Xutong Shen, Qingqing Li, Fanwen Wang, Jingxiao Bao, Mengting Dai, Heng Zheng & Xingzhen Lao. (2018) Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. Biomedicine & Pharmacotherapy 108, pages 610-617.
Crossref
Saori Suzuki, Hiroaki Annaka, Shota Konno, Izumi Kumagai & Ryutaro Asano. (2018) Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance. Scientific Reports 8:1.
Crossref
Jisoo Park, Yumi Lee, Byoung Joon Ko & Tae Hyeon Yoo. (2018) Peptide-Directed Photo-Cross-Linking for Site-Specific Conjugation of IgG. Bioconjugate Chemistry 29:10, pages 3240-3244.
Crossref
Fanwen Wang, Tingting Yu, Heng Zheng & Xingzhen Lao. (2018) Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life. Scientific Reports 8:1.
Crossref
Rob Peters & Tim Harris. (2018) Advances and innovations in haemophilia treatment. Nature Reviews Drug Discovery 17:7, pages 493-508.
Crossref
Pan Liu, Jan Wysocki, Tomokazu Souma, Minghao Ye, Veronica Ramirez, Bisheng Zhou, Lisa D. Wilsbacher, Susan E. Quaggin, Daniel Batlle & Jing Jin. (2018) Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation. Kidney International 94:1, pages 114-125.
Crossref
Tae Yoon Kim, Hyo-Deok Seo, Joong-jae Lee, Jung Ae Kang, Woo Sik Kim, Hye-Min Kim, Ha-Yeon Song, Ji Min Park, Dong-Eun Lee & Hak-Sung Kim. (2018) A dimeric form of a small-sized protein binder exhibits enhanced anti-tumor activity through prolonged blood circulation. Journal of Controlled Release 279, pages 282-291.
Crossref
Richard S. Blumberg & David Lillicrap. (2018) Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia. Blood 131:20, pages 2205-2214.
Crossref
Dongfen Yuan, Frederik Rode & Yanguang Cao. (2018) A Minimal Physiologically Based Pharmacokinetic Model with a Nested Endosome Compartment for Novel Engineered Antibodies. The AAPS Journal 20:3.
Crossref
J. Mahlangu, G. Young, C. Hermans, V. Blanchette, E. Berntorp & E. Santagostino. (2018) Defining extended half-life rFVIII-A critical review of the evidence. Haemophilia 24:3, pages 348-358.
Crossref
Minzhi Yu, Mason M. Benjamin, Santhanakrishnan Srinivasan, Emily E. Morin, Ekaterina I. Shishatskaya, Steven P. Schwendeman & Anna Schwendeman. (2018) Battle of GLP-1 delivery technologies. Advanced Drug Delivery Reviews 130, pages 113-130.
Crossref
Diogo M. Magnani, Thomas F. Rogers, Nicholas J. Maness, Nathan D. Grubaugh, Nathan Beutler, Varian K. Bailey, Lucas Gonzalez-Nieto, Martin J. Gutman, Núria Pedreño-Lopez, Jaclyn M. Kwal, Michael J. Ricciardi, Tereance A. Myers, Justin G. Julander, Rudolf P. Bohm, Margaret H. Gilbert, Faith Schiro, Pyone P. Aye, Robert V. Blair, Mauricio A. Martins, Kathrine P. Falkenstein, Amitinder Kaur, Christine L. Curry, Esper G. Kallas, Ronald C. Desrosiers, Pascal J. Goldschmidt-Clermont, Stephen S. Whitehead, Kristian G. Andersen, Myrna C. Bonaldo, Andrew A. Lackner, Antonito T. Panganiban, Dennis R. Burton & David I. Watkins. (2018) Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature Communications 9:1.
Crossref
Jenny Chia, Jade Louber, Isabelle Glauser, Shirley Taylor, Greg T. Bass, Steve K. Dower, Paul A. Gleeson & Anne M. Verhagen. (2018) Half-life–extended recombinant coagulation factor IX–albumin fusion protein is recycled via the FcRn-mediated pathway. Journal of Biological Chemistry 293:17, pages 6363-6373.
Crossref
Paul J. Carter & Greg A. Lazar. (2017) Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nature Reviews Drug Discovery 17:3, pages 197-223.
Crossref
Asa Ohsaki, Nicholas Venturelli, Tess M. Buccigrosso, Stavroula K. Osganian, John Lee, Richard S. Blumberg & Michiko K. Oyoshi. (2018) Maternal IgG immune complexes induce food allergen–specific tolerance in offspring. Journal of Experimental Medicine 215:1, pages 91-113.
Crossref
Sandor Kerpel-Fronius. (2018) A short review of the pharmacokinetic behavior of biological medicinal agents for the clinical practice. Microchemical Journal 136, pages 270-274.
Crossref
Carole Heath & Dean Pettit. 2018. Challenges in Protein Product Development. Challenges in Protein Product Development 545 558 .
Daniel Dixon, Serguei Tchessalov & Bakul Bhatnagar. 2018. Challenges in Protein Product Development. Challenges in Protein Product Development 407 439 .
Nina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, Daniela Dietze‐Schroeder, Ira Indrakusuma, In Young Choi, Sung Hee Park, Young‐Mi Lee, Se Chang Kwon, Yeonjoo Kang, Marcus Hompesch & Jürgen Eckel. (2017) LAPS Insulin115 : A novel ultra‐long‐acting basal insulin with a unique action profile . Diabetes, Obesity and Metabolism 19:12, pages 1722-1731.
Crossref
Frank Driessler, Maricel G. Miguelino, Glenn F. Pierce, Robert T. Peters & Jurg M. Sommer. (2017) Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotype. Blood Coagulation & Fibrinolysis 28:7, pages 540-550.
Crossref
Yuki Shiga, Daisuke Murata, Akinori Sugimoto, Yuta Oshima, Minoru Tada, Akiko Ishii-Watabe, Kenichiro Imai, Kentaro Tomii, Takashi Takeuchi, Shinji Kagaya & Atsushi Sato. (2017) Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin. Molecular Pharmaceutics 14:9, pages 3025-3035.
Crossref
James S. Foster, Angela D. Williams, Sallie Macy, Tina Richey, Alan Stuckey, Daniel Craig Wooliver, Richa Koul-Tiwari, Emily B. Martin, Stephen J. Kennel & Jonathan S. Wall. (2017) A Peptide-Fc Opsonin with Pan-Amyloid Reactivity. Frontiers in Immunology 8.
Crossref
Akinori Hishiya & Keizo Koya. (2017) Artificial DnaJ Protein for protein production and conformational diseases. Scientific Reports 7:1.
Crossref
Aleksandra Sokolowska-Wedzina, Grzegorz Chodaczek, Julia Chudzian, Aleksandra Borek, Malgorzata Zakrzewska & Jacek Otlewski. (2017) High-Affinity Internalizing Human scFv-Fc Antibody for Targeting FGFR1-Overexpressing Lung Cancer. Molecular Cancer Research 15:8, pages 1040-1050.
Crossref
Sheridan M. Hoy. (2017) Eftrenonacog Alfa: A Review in Haemophilia B. Drugs 77:11, pages 1235-1246.
Crossref
Li-Chun Zheng, Xiao-Qing Wang, Kun Lu, Xiao-Ling Deng, Cheng-Wei Zhang, Hong Luo, Xu-Dong Xu, Xiao-Man Chen, Lu Yan, Yi-Qing Wang & Song-Lin Shi. (2017) Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells. Oncotarget 8:25, pages 41348-41363.
Crossref
Tarianna Stewart, William T. Koval, Samuel A. Molina, Suzanne M. Bock, James W. LillardJr.Jr., Russell F. Ross, Tejal A. Desai & Michael Koval. (2017) Calibrated flux measurements reveal a nanostructure-stimulated transcytotic pathway. Experimental Cell Research 355:2, pages 153-161.
Crossref
D. Levin, H.A.D. Lagassé, E. Burch, S. Strome, S. Tan, H. Jiang, Z.E. Sauna & B. Golding. (2017) Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model. Journal of Thrombosis and Haemostasis 15:4, pages 721-734.
Crossref
Maria Mancuso & Elena Santagostino. (2017) Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates. Journal of Clinical Medicine 6:4, pages 39.
Crossref
Abdullah F. U. H. Saeed, Rongzhi Wang, Sumei Ling & Shihua Wang. (2017) Antibody Engineering for Pursuing a Healthier Future. Frontiers in Microbiology 8.
Crossref
Mark L. Brader, Edward N. Baker, Michael F. Dunn, Thomas M. Laue & John F. Carpenter. (2017) Using X-Ray Crystallography to Simplify and Accelerate Biologics Drug Development. Journal of Pharmaceutical Sciences 106:2, pages 477-494.
Crossref
Li Zhou, Hsuan-Yao Wang, Shanshan Tong, Curtis T. Okamoto, Wei-Chiang Shen & Jennica L. Zaro. (2017) Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery. Biomaterials 117, pages 24-31.
Crossref
H.A. Daniel Lagassé, Aikaterini Alexaki, Vijaya L. Simhadri, Nobuko H. Katagiri, Wojciech Jankowski, Zuben E. Sauna & Chava Kimchi-Sarfaty. (2017) Recent advances in (therapeutic protein) drug development. F1000Research 6, pages 113.
Crossref
K.John Pasi, Kathelijn Fischer, Margaret Ragni, Beatrice Nolan, David J. Perry, Roshni Kulkarni, Margareth Ozelo, Johnny Mahlangu, Amy D. Shapiro, Ross I. Baker, Carolyn M. Bennett, Christopher Barnes, Johannes Oldenburg, Tadashi Matsushita, Huixing Yuan, Alejandra Ramirez-Santiago, Glenn F. Pierce, Geoffrey Allen & Baisong Mei. (2017) Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B. Thrombosis and Haemostasis 117:03, pages 508-518.
Crossref
Kim Schafer, James Munn, Kate Khair, Neelam Thukral, Angela Tom & Sally McAlister. (2017) Pharmacokinetics, Safety, and Efficacy of Recombinant Factor VIII Fc Fusion Protein. Journal of Infusion Nursing 40:1, pages 65-75.
Crossref
Wenwen Dong, Hao Zhang, He Huang, Jianbo Zhou, Liping Hu, Ailing Lian, Lijun Zhu, Ningning Ma, Pingping Yang, Kai Wei & Ruiliang Zhu. (2016) Chicken IgY Fc Linked to Bordetella avium ompA and Taishan Pinus massoniana Pollen Polysaccharide Adjuvant Enhances Macrophage Function and Specific Immune Responses. Frontiers in Microbiology 7.
Crossref
Hyo Jung Julie Chang, Michael O'Boyle, Ronald C. Anderson & Chompoonut Suttikun. (2016) An fMRI study of advertising appeals and their relationship to product attractiveness and buying intentions. Journal of Consumer Behaviour 15:6, pages 538-548.
Crossref
Martin Whitham & Mark A. Febbraio. (2016) The ever-expanding myokinome: discovery challenges and therapeutic implications. Nature Reviews Drug Discovery 15:10, pages 719-729.
Crossref
Jiang-Jiang Qin, Wei Wang, Sushanta Sarkar & Ruiwen Zhang. (2016) Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis. Journal of Controlled Release 237, pages 101-114.
Crossref
James E. Frampton. (2016) Efmoroctocog Alfa: A Review in Haemophilia A. Drugs 76:13, pages 1281-1291.
Crossref
P.M. Mannucci, M.E. Mancuso & M. Franchini. (2016) Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A. Journal of Thrombosis and Haemostasis 14:7, pages 1330-1336.
Crossref
P. Collins, E. Chalmers, P. Chowdary, D. Keeling, M. Mathias, J. O'Donnell, K. J. Pasi, S. Rangarajan & A. Thomas. (2016) The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO . Haemophilia 22:4, pages 487-498.
Crossref
B. Brand, R. Gruppo, T. T. Wynn, L. Griskevicius, M. F. Lopez Fernandez, M. Chapman, T. Dvorak, B. G. Pavlova & B. E. Abbuehl. (2016) Efficacy and safety of pegylated full‐length recombinant factor VIII with extended half‐life for perioperative haemostasis in haemophilia A patients . Haemophilia 22:4.
Crossref
João Pedro Martins, Patrick J. Kennedy, Hélder A. Santos, Cristina Barrias & Bruno Sarmento. (2016) A comprehensive review of the neonatal Fc receptor and its application in drug delivery. Pharmacology & Therapeutics 161, pages 22-39.
Crossref
Yao-Yun Fan & Hendrik Neubert. (2016) Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS. Analytical Chemistry 88:8, pages 4239-4247.
Crossref
Saman Soleimanpour, Ali Mohammadi, Kiarash Ghazvini, Saeid Amel Jamehdar, Hamid Sadeghian, Mahboubeh Taghiabadi & S.A.R. Rezaee. (2016) Construction of Mycobacterium tuberculosis ESAT-6 fused to human Fcγ of IgG1: To target FcγR as a delivery system for enhancement of immunogenicity. Gene 580:2, pages 111-117.
Crossref
Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Pat Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie & Jan Terje Andersen. (2016) Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization. Journal of Controlled Release 223, pages 42-52.
Crossref
Manuel Carcao & Alok Srivastava. (2016) Factor VIII/factor IX prophylaxis for severe hemophilia. Seminars in Hematology 53:1, pages 3-9.
Crossref
Atsushi Furukawa, Katsumi Maenaka & Takao Nomura. 2016. Advanced Methods in Structural Biology. Advanced Methods in Structural Biology 67 81 .
Brian A. BaldoBrian A. Baldo. 2016. Safety of Biologics Therapy. Safety of Biologics Therapy 263 307 .
Jennifer A. Dumont, Kenneth S. Loveday, David R. Light, Glenn F. Pierce & Haiyan Jiang. (2015) Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc fusion protein in animals. Thrombosis Research 136:6, pages 1266-1272.
Crossref
Saman Soleimanpour, Hadi Farsiani, Arman Mosavat, Kiarash Ghazvini, Mohammad Reza Akbari Eydgahi, Mojtaba Sankian, Hamid Sadeghian, Zahra Meshkat & Seyed Abdolrahim Rezaee. (2015) APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Applied Microbiology and Biotechnology 99:24, pages 10467-10480.
Crossref
Keith Wycoff, James Maclean, Archana Belle, Lloyd Yu, Y Tran, Chad Roy & Frederick Hayden. (2015) Anti‐infective immunoadhesins from plants. Plant Biotechnology Journal 13:8, pages 1078-1093.
Crossref
Tal Noy-Porat, Ofer Cohen, Sharon Ehrlich, Eyal Epstein, Ron Alcalay & Ohad Mazor. (2015) Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-Life. Bioconjugate Chemistry 26:8, pages 1753-1758.
Crossref
G. Young, J. Mahlangu, R. Kulkarni, B. Nolan, R. Liesner, J. Pasi, C. Barnes, S. Neelakantan, G. Gambino, L. M. Cristiano, G. F. Pierce & G. Allen. (2015) Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A. Journal of Thrombosis and Haemostasis 13:6, pages 967-977.
Crossref
Michal Pyzik, Timo Rath, Wayne I. Lencer, Kristi Baker & Richard S. Blumberg. (2015) FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin. The Journal of Immunology 194:10, pages 4595-4603.
Crossref
Brian A. Baldo. (2015) Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety. Drug Safety 38:5, pages 455-479.
Crossref
Daniel M. Czajkowsky, Jan Terje Andersen, Anja Fuchs, Timothy J. Wilson, David Mekhaiel, Marco Colonna, Jianfeng He, Zhifeng Shao, Daniel A. Mitchell, Gang Wu, Anne Dell, Stuart Haslam, Katy A. Lloyd, Shona C. Moore, Inger Sandlie, Patricia A. Blundell & Richard J. Pleass. (2015) Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications. Scientific Reports 5:1.
Crossref
Céline Monnet, Sylvie Jorieux, Rémi Urbain, Nathalie Fournier, Khalil Bouayadi, Christophe De Romeuf, Christian K. Behrens, Alexandre Fontayne & Philippe Mondon. (2015) Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions. Frontiers in Immunology 6.
Crossref
Timo Rath, Kristi Baker, Michal Pyzik & Richard S. Blumberg. (2015) Regulation of Immune Responses by the Neonatal Fc Receptor and Its Therapeutic Implications. Frontiers in Immunology 5.
Crossref
Ditza Levin, Basil Golding, Scott E. Strome & Zuben E. Sauna. (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends in Biotechnology 33:1, pages 27-34.
Crossref
Uli Binder & Arne Skerra. 2015. Biobetters. Biobetters 269 311 .
A. D. Shapiro, M. V. Ragni, R. Kulkarni, J. Oldenberg, A. Srivastava, D. V. Quon, K. J. Pasi, H. Hanabusa, I. Pabinger, J. Mahlangu, P. Fogarty, D. Lillicrap, S. Kulke, J. Potts, S. Neelakantan, I. Nestorov, S. Li, J. A. Dumont, H. Jiang, A. Brennan & G. F. Pierce. (2014) Recombinant factor  VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von W illebrand factor levels . Journal of Thrombosis and Haemostasis 12:11, pages 1788-1800.
Crossref
Jurg Sommer, Yang Buyue, Sara Bardan, Robert Peters, Haiyan Jiang, George Kamphaus, Elaine Gray & Glenn Pierce. (2017) Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity. Thrombosis and Haemostasis 112:11, pages 932-940.
Crossref
Kristi Baker, Timo Rath, Michal Pyzik & Richard S. Blumberg. (2014) The Role of FcRn in Antigen Presentation. Frontiers in Immunology 5.
Crossref
J. McCue, D. Osborne, J. Dumont, R. Peters, B. Mei, G. F. Pierce, K. Kobayashi & D. Euwart. (2014) Validation of the manufacturing process used to produce long‐acting recombinant factor IX Fc fusion protein . Haemophilia 20:4.
Crossref
M. Carcao. (2014) Changing paradigm of prophylaxis with longer acting factor concentrates. Haemophilia 20, pages 99-105.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.